别名 Childhood Tic Disorder、Childhood Tic Disorders、Chronic Motor or Vocal Tic Disorder + [85] |
简介 Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994) |
靶点- |
作用机制- |
在研机构 |
原研机构 |
在研适应症 |
非在研适应症- |
最高研发阶段批准上市 |
首次获批国家/地区 中国 |
首次获批日期2019-12-18 |
靶点 |
作用机制 VMAT2抑制剂 |
最高研发阶段批准上市 |
首次获批国家/地区 美国 |
首次获批日期2017-04-11 |
靶点 |
作用机制 VMAT2抑制剂 |
非在研适应症 |
最高研发阶段批准上市 |
首次获批国家/地区 美国 |
首次获批日期2017-04-03 |
开始日期2024-06-01 |
申办/合作机构 University of Skövde [+6] |
开始日期2024-06-01 |
申办/合作机构 复旦大学附属儿科医院 [+1] |
开始日期2024-05-31 |
申办/合作机构 Noema Pharma AG初创企业 |